What is IQVIA's SG&A?

IQVIA (IQV) reported SG&A of $502M in Q1 2026.

How has IQVIA's SG&A changed year-over-year?

IQVIA's SG&A decreased by 1.2% year-over-year, from $508M to $502M.

What is the long-term trend for IQVIA's SG&A?

Over 4 years (2021 to 2025), IQVIA's SG&A has grown at a 0.4% compound annual growth rate (CAGR), from $1.96B to $2B.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

IQVIA IQV SG&A

SG&A at other companies

Thermo Fisher ScientificTMO

$2.18B+5.0%

UnitedHealth GroupUNH

$15.39B+13.2%

Labcorp HoldingsLH

$551M+0.9%

CognizantCTSH

$791M0.0%

Medpace Holdings, Inc.MEDP

$47.92M-17.2%

Tempus AI, Inc.TEM

$212.59M+37.5%

Segments

By segment

See full

Commercial Solutions$252M—

Research & Development Solutions$250M+8.7%

Other financials

Income statement

See full

Revenue$4.2B+8.4%

Gross profit$1.4B+4.4%

Operating income$514.0M+3.6%

Net income$274.0M+10.0%

EPS (diluted)$1.61+15.0%

Balance sheet

See full

Cash & equivalents$1.9B+11.9%

Total debt$16.1B+10.7%

Total equity$6.2B+4.1%

Total assets$29.7B+8.6%

Cash flow

See full

Operating cash flow$618.0M+8.8%

CapEx$127.0M-10.6%

Free cash flow$491.0M+15.3%

Valuation

See full

Market cap$32.25B+17.5%

Enterprise value$46.37B+12.8%

P/E23.3×+1.1×

P/S1.9×+0.2×

Profitability

See full

Gross margin33%-1.7pp

Operating margin13.2%-0.9pp

Net margin8.3%-0.3pp

FCF margin12.7%-1.2pp

Returns & leverage

See full

Return on equity22.7%+1.1pp

Debt / equity2.6×+0.2×

Current ratio0.7×-0.1×

Where this comes from

Reported directly by IQVIA in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: IQVIA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IQVIA's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is IQVIA's SG&A?: IQVIA (IQV) reported SG&A of $502M in Q1 2026.
How has IQVIA's SG&A changed year-over-year?: IQVIA's SG&A decreased by 1.2% year-over-year, from $508M to $502M.
What is the long-term trend for IQVIA's SG&A?: Over 4 years (2021 to 2025), IQVIA's SG&A has grown at a 0.4% compound annual growth rate (CAGR), from $1.96B to $2B.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.